APA
Curtis J. R., Wright G. C., Strand V., Davis C. S., Hitraya E. & Sasso E. H. (20190430). Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al. : Arthritis & rheumatology (Hoboken, N.J.).
Chicago
Curtis Jeffrey R, Wright Grace C, Strand Vibeke, Davis Charles S, Hitraya Elena and Sasso Eric H. 20190430. Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al. : Arthritis & rheumatology (Hoboken, N.J.).
Harvard
Curtis J. R., Wright G. C., Strand V., Davis C. S., Hitraya E. and Sasso E. H. (20190430). Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al. : Arthritis & rheumatology (Hoboken, N.J.).
MLA
Curtis Jeffrey R, Wright Grace C, Strand Vibeke, Davis Charles S, Hitraya Elena and Sasso Eric H. Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al. : Arthritis & rheumatology (Hoboken, N.J.). 20190430.